Skip to content

H3K9 lactylation transcriptionally activates EHMT2 to drive pulmonary arterial hypertension via PPARγ repression.

Nov 2026 · European Journal of Pharmacology · pp. 179551 · 0 citations · 45 references
Medicine

Abstract

Pulmonary arterial hypertension (PAH) is characterized by excessive proliferation and migration of pulmonary arterial smooth muscle cells (PASMCs), yet how hypoxia-associated metabolic reprogramming contributes to pulmonary vascular remodeling remains unclear. Here, we show that hypoxia elevates intracellular lactate in PASMCs, promoting HBO1 (lysine acetyltransferase 7/KAT7)-catalyzed H3K9 lactylation (H3K9la) at the EHMT2 promoter and enhancing EHMT2 transcription. Smooth muscle cell-specific Ehmt2 deletion attenuates pulmonary vascular remodeling and right ventricular hypertrophy in SU5416/hypoxia (SuHx) mice and suppresses PASMC proliferation and migration. Conversely, EHMT2 overexpression promotes these phenotypes and mediates lactate-induced PASMC dysfunction. RNA sequencing of pulmonary arteries from Ehmt2-deficient mice identifies PPARγ repression as a downstream mechanism. EHMT2 inhibits PPARγ nuclear translocation, whereas rosiglitazone ameliorates EHMT2-induced PASMC dysfunction. Moreover, administration of lactate exacerbates SuHx-induced PAH in an EHMT2-dependent manner. Collectively, these findings identify a lactate-H3K9la-EHMT2-PPARγ axis linking hypoxia-induced metabolic reprogramming to pulmonary vascular remodeling and PAH progression.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.